Cardiff Oncology Appoints Dr. Leila Alland as Interim Chief Medical Officer
Position
Chief Medical Officer
Company
Cardiff Oncology
San DiegoBiotechnologyHealth CareScience And EngineeringDescription
Effective October 23, 2026, Dr. Leila Alland has been appointed as the interim Chief Medical Officer of Cardiff Oncology, Inc. following the departure of Dr
Quick answer
Cardiff Oncology Appoints Dr. Leila Alland as Interim Chief Medical Officer (October 27, 2026). Cardiff Oncology is based in San Diego, California, United States.
- Who is the new Chief Medical Officer at Cardiff Oncology?
- Cardiff Oncology named Leila Alland Chief Medical Officer, announced October 27, 2026.
- What did Cardiff Oncology announce on October 27, 2026?
- Effective October 23, 2026, Dr. Leila Alland has been appointed as the interim Chief Medical Officer of Cardiff Oncology, Inc. following the departure of Dr
- What does Cardiff Oncology do?
- Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers.
- Where is Cardiff Oncology based?
- Cardiff Oncology is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Thermo Fisher Scientific (October 30, 2026), Intellia Therapeutics, Inc. (October 18, 2026), The Hain Celestial Group (October 15, 2026) and Enliven Therapeutics (October 14, 2026) also announced leadership changes within 45 days of Cardiff Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Michael D. Shafer to Retire from Thermo Fisher Scientific (October 30, 2026)
- Intellia Therapeutics Appoints Jing L. Marantz as Chief Medical Officer (October 18, 2026)
- Hain Celestial Appoints Patricia Ferrari and Richard Shinder as New Directors (October 15, 2026)
- Enliven Therapeutics Appoints Kristine Ball as Class II Director (October 14, 2026)
- Nomad Power Solutions Appoints Michael Hilmer as Consultant Following CEO Departure (November 10, 2026)
- Kevin Howard Appointed Interim Chief Financial Officer at Charter Communications (October 27, 2026)
Who to call at Cardiff Oncology, and when
A new leader at Cardiff Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cardiff Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cardiff Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cardiff Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cardiff Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cardiff Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.